Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.62M | $170M | -99.05% |
Operating Income | $-401.98M | $-292.12M | -37.61% |
Net Income | $-328.94M | $-242.96M | -35.39% |
EPS (Basic) | $-3.92 | $-3.07 | -27.69% |
EPS (Diluted) | $-3.92 | $-3.07 | -27.69% |
R&D Expense | $238.5M | $292.19M | -18.38% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.26B | $2.09B | +8.11% |
Current Assets | $1.94B | $1.76B | +10.41% |
Total Liabilities | $316.47M | $359.04M | -11.86% |
Current Liabilities | $89.81M | $111.23M | -19.26% |
Stockholders' Equity | $1.94B | $1.73B | +12.26% |
Cash & Equivalents | $225.67M | $527.76M | -57.24% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-92.74M | $-164.3M | +43.55% |
Investing Cash Flow | $-386.31M | $456.1M | -184.70% |
Financing Cash Flow | $315.11M | $23.73M | +1228.17% |
D&A | $14.42M | $14.94M | -3.48% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -24767.6% | -171.8% | -24595.75% |
Net Margin | -20267.5% | — | — |
ROE | -17.0% | — | — |
ROA | -14.6% | — | — |
Current Ratio | $21.644 | — | — |
Debt to Equity | $0.163 | — | — |
Other companies in Biotechnology